Publicação científica trimestral do CREMERJ - volume 2 - número 3 - 2023

97 Med. Ciên. e Arte , Rio de Janeiro, v.2, n.3, p.80-100, jul-set 2023 Febre amarela: uma trilha inacabada Terezinha Marta Pereira Pinto Castiñeiras, Luciana Gomes Pedro Brandão, Guilherme Sant'Anna de Lira 7. Centers for Disease Control and Prevention. Transmission of Yellow Fever Virus [Internet]. 2019. Acesso: em 24 nov de 2023. Disponível em: https://www.cdc.gov/yellowfever/transmission/index.html 8. Couto-Lima D, Madec Y, Bersot MI, Campos SS, Motta M de A, Santos FBD, et al. Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations. Sci Rep 2017;7(1):4848. DOI: 10.1038/s41598-017-05186-3 9. Benedict MQ, Levine RS, Hawley WA, Lounibos LP. Spread of The Tiger: Global Risk of Invasion by The Mosquito Aedes albopictus . Vector-Borne and Zoonotic Diseases 2007;7(1):76–85. DOI: 10.1089/ vbz.2006.0562 10. Monath TP, Vasconcelos PFC. Yellow fever. J Clin Virol 2015;64:160-73. DOI: 10.1016/j.jcv.2014.08.030 11. Gaythorpe KAM, Jean K, Cibrelus L, Garske T. Quantifying model evidence for yellow fever transmission routes in Africa. Ferrari M (Matt), organizador. PLoS Comput Biol 2019;15(9):e1007355. DOI: 10.1371/ journal.pcbi.1007355 12. Hamer DH. Fatal Yellow Fever in Travelers to Brazil, 2018. MMWRMorb Mortal Wkly Rep 2018;67(11):340- 341. DOI: 10.15585/mmwr.mm6711e1 13. Ho YL, Joelsons D, Leite GFC, Malbouisson LMS, Song ATW, Perondi B, et al. Severe yellow fever in Brazil: clinical characteristics and management. J Travel Med 2019;26(5):taz040. DOI: 10.1093/jtm/taz040 14. Kallas EG, D’Elia Zanella LGFAB, Moreira CHV, Buccheri R, Diniz GBF, Castiñeiras ACP, et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis 2019;19(7):750-8. DOI: 10.1016/S1473-3099(19)30125-2 15. Lindsey NP, Horton J, Barrett ADT, Demanou M, Monath TP, Tomori O, et al. Yellow fever resurgence: An avoidable crisis? npj Vaccines 2022;7(1):1-3. DOI: 10.1038/s41541-022-00552-3 16. Grobbelaar AA, Weyer J, Moolla N, Jansen van Vuren P, Moises F, Paweska JT. Resurgence of Yellow Fever in Angola, 2015–2016. Emerg Infect Dis 2016;22(10):1854–5. DOI: 10.3201/eid2210.160818 17. Barrett ADT. The reemergence of yellow fever. Science 2018;361(6405):847–8. DOI: 10.1126/science.aau8225 18. Possas C, Lourenço-de-Oliveira R, Tauil PL, Pinheiro F de P, Pissinatti A, Cunha RV da, et al. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Mem Inst Oswaldo Cruz 2018;113(10): e180278. DOI: 10.1590 /0074-02760180278 19. Silva NIO, Sacchetto L, de Rezende IM, Trindade G de S, LaBeaud AD, de Thoisy B, et al. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease. Virology Journal 2020;17(1):9. DOI: 10.1186/s12985-019-1277-7 20. Faria NR, Kraemer MUG, Hill SC, Goes De Jesus J, Aguiar RS, Iani FCM, et al. Genomic and epidemiological monitoring of yellow fever virus transmission potential. Science 2018;361(6405):894–9. DOI: 10.1126/ science.aat7115 21. World Health Organization. Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response: WHO Secretariat information paper. 2016. Acesso em: 15 dez de 2023. Disponível em: https:// iris.who.int/handle/10665/246236 22. Roukens AHE, Visser LG. Fractional-dose yellow fever vaccination: an expert review. Journal of Travel Medicine 2019;26(6):taz024. DOI: 10.1093/jtm/taz024 23. Martins RM, Maia M de LS, Farias RHG, Camacho LAB, Freire MS, Galler R, et al. 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother 2013;9(4):879-88. DOI: 10.4161/hv.22982 24. Juan-Giner A, Kimathi D, Grantz KH, Hamaluba M, Kazooba P, Njuguna P, et al. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Lancet 2021;397(10269):119-27. DOI: 10.1016/S0140-6736(20)32520-4 25. World Health Organization. A global strategy to eliminate yellow fever epidemics (EYE) 2017–2026 [Internet]. World Health Organization; 2018. Acesso em: 02 dez de 2023. 54 p. Disponível em: https:// apps.who.int/iris/handle/10665/272408